glp 1 needle How to Use GLP-1 Medication Safely GLP-1 Drugs For Weight Loss

The SURMOUNT-4 trial assessed the weight maintenance with tirzepatide and had also two periods: a 36-week open-label lead-in period during which all participants took tirzepatide, followed by a 52-week double-blind treatment period during which participants were randomised to either continue on tirzepatide or switch to placebo

Quality assessment of evidence We used the Cochrane randomised trial Risk of Bias tool (version 2.0) to assess the risk of bias in the included trials, including random sequence generation, assignment hiding, blinding, loss of result data, and selective reporting of results.28 If the risk of bias was low in all domains, the overall risk of bias in each trial was considered low (scored as 1)

The patented active ingredient, Amarasate, is encased in a delayed-release capsule for targeted release, triggering the bitter taste receptors (TAS2R) of enteroendocrine cells predominantly found along the duodenum

The molecules compatibility with prefilled pens and auto-injectors further supports efficient distribution through home delivery channels

Blood samples were collected through the tail vein